Kadner G, Valerio M, Giannakis I , Manit A, , Nicolaas L, Ho BSH, Alonso S, Shulman C, Barber N, Amparore D, Porpiglia F

Second generation  of temporary implantable nitinol device (iTIND) in men with LUTS: 2 year results of the MT-02-study.

World J Urol, 2020, Mar 2

 

Kadner G, Valerio M, Giannakis I , Manit A, , Nicolaas L, Ho BSH, Alonso S, Shulman C, Barber N, Amparore D, Porpiglia F

Second generation  of temporary implantable nitinol device (iTIND) in men with lower urinary tract symptoms (LUTS): Who profit most from treatment? 2 year results of the MT-02-study.

AUA Annual Congress 2020, May 15-18; EAU Annual Congress 2020, July 17-21

 

Giannakis I, Schell G, Rohrmann K, Anastasiadis A, Herrmann T.,Kadner G, 

Temporary Implantable Nitinol Generation II Device (i-TIND) for treatment of LUTS:  more than a bladder neck procedure?

Our experience with median lobe and acute urinary retention.

75. Jahresversammlung der Schweizer Gesellschaft für Urologie, Zürich, 04.09.-06.09.2019

 

Kadner G, Giannakis I, Schell G, Rohrmann K, Anastasiadis A, Herrmann T.

iTIND als minimalinvasive Therapieoption bei LUTS. 2 Jahres-Erfahrungen zu Indikationsspektrum, OP-Technik, perioperativen Management, Ergebnisqualität und Fragen der Abrechnung. 

75. Jahresversammlung der Schweizer Gesellschaft für Urologie, Zürich, 04.09.-06.09.2019

 

 

Kadner G, Giannakis I, Schell G, Rohrmann K, Anastasiadis A, Herrmann T.

Temporary Implantable Nitinol Generation II Device (i-TIND) for treatment of LUTS: more than a bladder neck procedure?

60. Jahrestagung der Südwestdeutschen Gesellschaft für Urologie, Stuttgart, 22.-25.05.2019

 

Porpiglia F, Fiori C, Amparore D, Kadner G, Manit A, Valerio M, Lumen N, Ho BS, Alonso S, Schulman C, Barber N.

Second-Generation of Temporary implantable nitinol device (i-TIND) for the relief of lower urinary tract symptoms due to BPH: results of a prospective, multi-center study at 1 year of follow-up.

 BJU Int. 2018 Nov 1. doi: 10.1111/bju.14608.

   

 

Porpiglia F, Fiori C, Amparore D, Manit A, Kadner G, Valerio M, Shulman C.

The new MediTate® temporary implantable nitinol device (i-TIND) in the treatment of bladder outlet obstruction due to BPH: results of one arm, multicenter prospective, study.

EAU-European Association of Urology 2017, Jahreskongress, 24.-28. März, London

 

 

Porpiglia F, Fiori C, Amparore D, Manit A, Kadner G, Valerio M, Shulman C.

The new MediTate® temporary implantable nitinol device (i-TIND) in the treatment of bladder outlet obstruction due to BPH: results of one arm, multicenter prospective, study.

EAU-European Association of Urology 2017, Jahreskongress, 24.-28. März, London

  

 

Kadner G, Rohrmann K, Schell G, Bräutigam R.

iTIND: Temporary Implantable Nitinol Device for treatment of symptomatic BPH.

EAU-European Association of Urology 2016, Jahreskongress,11.-15. März, München

  

 

Kadner G, Rohrmann K, Schell G, Bräutigam R.

iTIND: Temporary Implantable Nitinol Device for treatment of subject with symptomatic BPH. First experience with implantation and explantation, tips and tricks and pitfalls.

56. Jahrestagung der Südwestdeutschen Gesellschaft für Urologie, 06.-09. Mai 2015, Friedrichshafen

  

 

Kadner G, Haeufel J , Schulz C, Bräutigam R.

Minimalinvasive Therapie der symptomatischen Prostatahyperplasie mit dem Temporären Implantierbaren Nitinol-Device (iTIND). Erste Erfahrungen sowie  Tips und Tricks zur Implantation und Explantation.

71. Jahresversammlung Schweizer Gesellschaft für Urologie, 02.-04. Sept. 2015, St. Gallen

 

 

Porpiglia F, Fiori C, Bertolo R, Giordano A, Checcucci E, Garrou D, Cattaneo G, De Luca S, Amparore D.

3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction.

BJU Int. 2018 Jul;122(1):106-112. doi: 10.1111/bju.14141. Epub 2018 Feb 14.

  

 

Porpiglia F, Fiori C, Bertolo R, Garrou D, Cattaneo G, Amparore D.

Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.

BJU Int. 2015 Aug;116(2):278-87. doi: 10.1111/bju.12982. Epub 2015 Mar 7.

 

 

 

Porpiglia F, Fiori C, Bertolo R, Giordano A, Checcucci E, Garrou D, Cattaneo G, De Luca S, Amparore D.

3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction.

BJU Int. 2018 Jul;122(1):106-112. doi: 10.1111/bju.14141. Epub 2018 Feb 14.

 

 

 

 

Bertolo R, Fiori C, Amparore D, Porpiglia F.

Follow-up of Temporary Implantable Nitinol Device (TIND) Implantation for the Treatment of BPH: a Systematic Review.

Curr Urol Rep. 2018 Apr 26;19(6):44. doi: 10.1007/s11934-018-0793-0.

 

 

 

Marcon J, Magistro G, Stief CG, Grimm T.

What's New in TIND?

Eur Urol Focus. 2018 Jan;4(1):40-42. doi: 10.1016/j.euf.2018.04.009. Epub 2018 Apr 26.